Intratracheal budesonide mixed with surfactant to increase survival free of BPD in extremely preterm infants: Results of the international PLUSS trial

Brett J.. Manley, The Royal Women's Hospital, Melbourne, Australia, Kensington, Victoria, Australia; C. Omar F. Kamlin, Royal Women's Hospital, LONDON, England, United Kingdom; Jennifer A. Dawson, The Royal Women's Hospital, Parkville, Victoria, Australia; Kate L. Francis, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Susan Donath, University of Melbourne, Melbourne, Victoria, Australia; Jeanie Cheong, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Peter Dargaville, Menzies Institute, University of Tasmania, Hobart, Tasmania, Australia; Susan E. Jacobs, Royal Women's Hospital, Parkville, Victoria, Australia; Pita Birch, Mater Health, South Brisbane, Queensland, Australia; Li Huang, The University of Melbourne, Melbourne, Victoria, Australia; Lex W. Doyle, Prof. Lex Doyle, Parkville, Victoria, Australia; Peter G. Davis, University of Melbourne, Melbourne, Victoria, Australia; Christopher JD. McKinlay, University of Auckland, Auckland, Auckland, New Zealand